A detailed history of Cape Investment Advisory, Inc. transactions in Haleon PLC stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 500 shares of HLN stock, worth $4,970. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Previous 647 22.72%
Holding current value
$4,970
Previous $5.34 Million 1.01%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$8.32 - $10.7 $1,223 - $1,572
-147 Reduced 22.72%
500 $5.29 Million
Q1 2024

Jun 21, 2024

BUY
$8.02 - $8.67 $360 - $390
45 Added 7.48%
647 $5.49 Million
Q2 2023

Oct 12, 2023

SELL
$8.04 - $9.0 $61,039 - $68,328
-7,592 Reduced 92.65%
602 $5.05 Million
Q1 2023

Oct 12, 2023

BUY
$7.57 - $8.37 $62,028 - $68,583
8,194 New
8,194 $66.7 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $45.9B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Cape Investment Advisory, Inc. Portfolio

Follow Cape Investment Advisory, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cape Investment Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cape Investment Advisory, Inc. with notifications on news.